Omniscan 287 mg (Gadodiamide SOLUTION) 287 MG

Omniscan 287 mg is a gadodiamide solution used for contrast enhancement in MRI scans. This intravenous solution aids in improving image clarity for better diagnostic results.

Strength

287 MG

Pack Size

5/10/15/20/50 ML

Manufacturer / TM Owner

GE HEALTHCARE CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Omniscan 287 mg is primarily used as a contrast agent in magnetic resonance imaging (MRI). It helps to enhance the visibility of internal structures, making it easier for healthcare professionals to identify abnormalities. This solution is often utilized in diagnostic procedures to improve the accuracy of MRI scans.

Side Effects

Omniscan 287 mg is designed to enhance the contrast in MRI images, which can help in detecting and evaluating various conditions. The solution works by altering the magnetic properties of tissues, making them more distinguishable in the scans. This can lead to clearer and more detailed images, aiding in the diagnostic process.

Precautions & Warnings

Omniscan 287 mg should be used under the supervision of a healthcare professional. It is important to inform your healthcare provider about any allergies or medical conditions before administration. Follow the prescribed guidelines for safe and effective use.

Avoid Interactions

Omniscan 287 mg may interact with certain medications or medical conditions. It is advisable to discuss your current medications and health status with a healthcare professional before using this contrast agent. Always follow the advice of your healthcare provider to minimize potential risks.

Frequently Asked Questions

Omniscan 287 mg is used as a contrast agent to enhance the visibility of internal structures during MRI scans.

Omniscan 287 mg is administered intravenously by a healthcare professional during an MRI procedure.

Omniscan 287 mg enhances the contrast in MRI images, making internal structures more visible and aiding in diagnostic accuracy.

Yes, it is important to inform your healthcare provider about any allergies or medical conditions before using Omniscan 287 mg.

Omniscan 287 mg may interact with certain medications or medical conditions, so it is advisable to discuss your health status with a healthcare professional.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.